Leurgans SE - Search Results

1

Single-blind clinical trial of psychotherapy for treatment of psychogenic movement disorders.

Hinson VK, Weinstein S, Bernard B, Leurgans SE, Goetz CG. Hinson VK, et al. Among authors: leurgans se. Parkinsonism Relat Disord. 2006 Apr;12(3):177-80. doi: 10.1016/j.parkreldis.2005.10.006. Epub 2005 Dec 20. Parkinsonism Relat Disord. 2006. PMID: 16364676 Clinical Trial.

2

Rating scale for psychogenic movement disorders: scale development and clinimetric testing.

Hinson VK, Cubo E, Comella CL, Goetz CG, Leurgans S. Hinson VK, et al. Mov Disord. 2005 Dec;20(12):1592-7. doi: 10.1002/mds.20650. Mov Disord. 2005. PMID: 16108025

3

Short-term and practice effects of metronome pacing in Parkinson's disease patients with gait freezing while in the 'on' state: randomized single blind evaluation.

Cubo E, Leurgans S, Goetz CG. Cubo E, et al. Parkinsonism Relat Disord. 2004 Dec;10(8):507-10. doi: 10.1016/j.parkreldis.2004.05.001. Parkinsonism Relat Disord. 2004. PMID: 15542012 Clinical Trial.

4

Transcultural comparison of psychogenic movement disorders.

Cubo E, Hinson VK, Goetz CG, Garcia Ruiz P, Garcia de Yebenes J, Marti MJ, Rodriguez Oroz MC, Linazasoro G, Chacón J, Vázquez A, López del Val J, Leurgans S, Wuu J. Cubo E, et al. Mov Disord. 2005 Oct;20(10):1343-5. doi: 10.1002/mds.20561. Mov Disord. 2005. PMID: 16001406

5

Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients.

Hinson VK, Goetz CG, Leurgans S, Fan W, Nguyen T, Hsu A. Hinson VK, et al. Clin Neuropharmacol. 2009 Jul-Aug;32(4):189-92. doi: 10.1097/WNF.0b013e3181a27fae. Clin Neuropharmacol. 2009. PMID: 19620848 Clinical Trial.

6

Evaluating Parkinson's disease patients at home: utility of self-videotaping for objective motor, dyskinesia, and ON-OFF assessments.

Goetz CG, Leurgans S, Hinson VK, Blasucci LM, Zimmerman J, Fan W, Nguyen T, Hsu A. Goetz CG, et al. Mov Disord. 2008 Jul 30;23(10):1479-82. doi: 10.1002/mds.22127. Mov Disord. 2008. PMID: 18512751

7

Wheeled and standard walkers in Parkinson's disease patients with gait freezing.

Cubo E, Moore CG, Leurgans S, Goetz CG. Cubo E, et al. Parkinsonism Relat Disord. 2003 Oct;10(1):9-14. doi: 10.1016/s1353-8020(03)00060-9. Parkinsonism Relat Disord. 2003. PMID: 14499200 Clinical Trial.

8

Gilles de la Tourette syndrome: patient's knowledge and concern of adverse effects.

Kompoliti K, Goetz CG, Morrissey M, Leurgans S. Kompoliti K, et al. Mov Disord. 2006 Feb;21(2):248-52. doi: 10.1002/mds.20680. Mov Disord. 2006. PMID: 16161137

9

The malignant course of "benign hallucinations" in Parkinson disease.

Goetz CG, Fan W, Leurgans S, Bernard B, Stebbins GT. Goetz CG, et al. Arch Neurol. 2006 May;63(5):713-6. doi: 10.1001/archneur.63.5.713. Arch Neurol. 2006. PMID: 16682540

10

Antipsychotic medication treatment for mild hallucinations in Parkinson's disease: Positive impact on long-term worsening.

Goetz CG, Fan W, Leurgans S. Goetz CG, et al. Mov Disord. 2008 Aug 15;23(11):1541-5. doi: 10.1002/mds.22132. Mov Disord. 2008. PMID: 18567004 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

331 results

Search Page

Filters